CureVac starts clinical trial for Covid-19 vaccine candidateAdults, Clinical Trials, COVID-19 Vaccines, Europe, Immunogenicity Data, Latin America, Messenger RNA (mRNA) Vaccines, R&D, Safety Data, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)German biotech firm CureVac enrolled the first participant for a Phase 2b/3 clinical trial of the company’s Covid-19 vaccine candidate. Read more December 14, 2020/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/11/CureVacs-COVID-19-vaccine-triggers-immune-response-in-Phase-I-trial-Reuters-11-2-20.jpeg 246 370 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2020-12-14 10:54:352020-12-14 23:29:12CureVac starts clinical trial for Covid-19 vaccine candidate